Dezamizumab Biosimilar - Research Grade

Human

APCSï؟½

5mg/ml

IgG1 - kappa

CHO Cells

https://www.imgt.org/mAb-DB/

ICH3002

P02743

Blue ice

Serum amyloid P component (APCS) is a plasma protein that binds amyloid deposits and modulates their clearance, making it a target of interest in amyloidosis research. Offered as an unconjugated, non-therapeutic analog of dezamizumab, this human IgG1-kappa recombinant antibody is intended for research use only. It is provided low in endotoxin to in vivo standards and manufactured in scalable milligram-to-gram quantities for high-throughput laboratories. The antibody supports functional and binding assays, amyloid-clearance studies, in vitro screening and preclinical models examining serum amyloid P biology, with consistent lot-to-lot reproducibility.

Serum amyloid P-component, SAP, PTX2

This monoclonal antibody was purified using Protein A

Sterile, preservative-free, solution in PBS. BSA and Azide free.

This biosimilar is stable when stored at 2-8°C. For longer term storage (> 3 months) it is recommended to store this antibody at -20°C or -70°C.

Functional Assays

This biosimilar is for research use only (RUO): it is not for diagnostic or therapeutic procedures and cannot be purchased by patients.

Products are for research use only. Not for use in diagnostic or therapeutic procedures.

3-4 weeks